Manganese induces p21 expression in PC12 cells at the transcriptional level

Neuroscience

Volumn 215, Issue , 2012, Pages 184-195

  Zhao, F ^a   Zhang, J B ^a   Cai, T J ^a   Liu, X Q ^a   Liu, M C ^a   Ke, T ^a   Chen, J Y ^a   Luo, W J ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Manganese; P21; PC12 cells; Regulatory mechanism

Indexed keywords

MANGANESE; MESSENGER RNA; PROTEIN P21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CELL DAMAGE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; G2 PHASE CELL CYCLE CHECKPOINT; GENE INDUCTION; IN VITRO STUDY; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STABILITY; RAT; RNA INTERFERENCE; TRANSCRIPTION INITIATION; UPREGULATION;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; CELL CYCLE; CELL SURVIVAL; CHLORIDES; CORPUS STRIATUM; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; MALE; MANGANESE COMPOUNDS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

EID: 84861799915     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.04.027     Document Type: Article

References (56)

1. Abukhdeir A.M., Park B.H. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev. Mol. Med. 2008, 10:e19.
2. Aschner J.L., Aschner M. Nutritional aspects of manganese homeostasis. Mol. Aspects Med. 2005, 26:353-362.
3. Benedetto A., Au C., Avila D.S., Milatovic D., Aschner M. Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet. 2010, 6(8). pii: e1001084.
4. Blagosklonny M.V., Wu G.S., Omura S., el-Deiry W.S. Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem. Biophys. Res. Commun. 1996, 227:564-569.
5. Bloom J., Amador V., Bartolini F., DeMartino G., Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 2003, 115:71-82.
6. Brugarolas J., Moberg K., Boyd S.D., Taya Y., Jacks T., Lees J.A. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc. Natl. Acad. Sci. U S A 1999, 96:1002-1007.
7. Burton N.C., Guilarte T.R. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ. Health Perspect. 2009, 117(3):325-332.
8. Cartelli D., Ronchi C., Maggioni M.G., Rodighiero S., Giavini E., Cappelletti G. Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+-induced neurodegeneration. J. Neurochem. 2010, 115:247-258.
9. Cayrol C., Knibiehler M., Ducommun B. P21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 1998, 16:311-320.
10. Cazzalini O., Scovassi A.I., Savio M., Stivala L.A., Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 2010, 704:12-20.
11. Cersosimo M.G., Koller W.C. The diagnosis of manganese-induced parkinsonism. Neurotoxicology 2006, 27:340-346.
12. Cheng J., Fu J., Zhou Z. The mechanism of manganese-induced inhibition of steroidogenesis in rat primary Leydig cells. Toxicology 2005, 211:1-11.
13. Coller H.A., Grandori C., Tamayo P., Colbert T., Lander E.S., Eisenman R.N., Golub T.R. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. U S A 2000, 97:3260-3265.
14. Coqueret O. New roles for p21 and p27 cell cycle inhibitors: a function for each cell compartment?. Trends Cell Biol. 2003, 13:65-70.
15. Deng Y., Luan Y., Qing H., Xie H., Lu J., Zhou J. The formation of catechol isoquinolines in PC12 cells exposed to manganese. Neurosci. Lett. 2008, 444(2):122-126.
16. Dulic V., Stein G.H., Far D.F., Reed S.I. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol. 1998, 18(1):546-557.
17. el-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994, 54:1169-1174.
18. Engidawork E., Gulesserian T., Seidl R., Cairns N., Lubec G. Expression of apoptosis related proteins in brains of patients with Alzheimer's disease. Neurosci. Lett. 2001, 303:79-82.
19. Erikson K.M., Dobson A.W., Dorman D.C., Aschner M. Manganese exposure and induced oxidative stress in the rat brain. Sci. Total Environ. 2004, 334-335:409-416.
20. Fang Z., Fu Y., Liang Y., Li Z., Zhang W., Jin J., Yang Y., Zha X. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells. J. Cell. Biochem. 2007, 101(3):654-664.
21. Giles K.M., Daly J.M., Beveridge D.J., Thomson A.M., Voon D.C., Furneaux H.M., Jazayeri J.A., Leedman P.J. The 3'-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein. J. Biol. Chem. 2003, 278:2937-2946.
22. Gillis L.D., Leidal A.M., Hill R., Lee P.W. P21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage. Cell Cycle 2009, 8:253-256.
23. Gorospe M., Wang X., Holbrook N.J. P53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system. Mol. Cell. Biol. 1998, 18:1400-1407.
24. Goubin F., Ducommun B. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 1995, 10:2281-2287.
25. Guilarte T.R., Burton N.C., McGlothan J.L., Verina T., Zhou Y., Alexander M., Pham L., Griswold M., Wong D.F., Syversen T., Schneider J.S. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. J. Neurochem. 2008, 107:1236-1247.
26. Gulbis J.M., Kelman Z., Hurwitz J., O'Donnell M., Kuriyan J. Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA. Cell 1996, 87:297-306.
27. Gunter T.E., Gavin C.E., Aschner M., Gunter K.K. Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity. Neurotoxicology 2006, 27:765-776.
28. Hoglinger G.U., Breunig J.J., Depboylu C., Rouaux C., Michel P.P., Alvarez-Fischer D., Boutillier A.L., Degregori J., Oertel W.H., Rakic P., Hirsch E.C., Hunot S. The pRb/E2F cell cycle pathway mediates cell death in Parkinson's disease. Proc. Natl. Acad. Sci. U S A 2007, 104:3585-3590.
29. Jascur T., Brickner H., Salles-Passador I., Barbier V., El Khissiin A., Smith B., Fotedar R., Fotedar A. Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein. Mol. Cell 2005, 17:237-249.
30. Jordan-Sciutto K.L., Dorsey R., Chalovich E.M., Hammond R.R., Achim C.L. Expression patterns of retinoblastoma protein in Parkinson disease. J. Neuropathol. Exp. Neurol. 2003, 62:68-74.
31. Kaiser J. Manganese: a high-octane dispute. Science 2003, 300:926-928.
32. Kim M.K., Kim S.C., Kang J.I., Hyun J.H., Boo H.J., Eun S.Y., Park D.B., Yoo E.S., Kang H.K., Kang J.H. 6-Hydroxydopamine-induced PC12 cell death is mediated by MEF2D down-regulation. Neurochem. Res. 2010, 36:223-231.
33. Lee J., Kim J.A., Barbier V., Fotedar A., Fotedar R. DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest. Mol. Biol. Cell 2009, 20:1891-1902.
34. Li H., Xie B., Rahmeh A., Zhou Y., Lee M.Y. Direct interaction of p21 with p50, the small subunit of human DNA polymerase delta. Cell Cycle 2006, 5:428-436.
35. Li H., Wu S., Shi N., Lin W., You J., Zhou W. NF-E2-related factor 2 activation in PC12 cells: its protective role in manganese-induced damage. Arch. Toxicol. 2011, 85(8):901-910.
36. Liu Y.M., Jiang B., Bao Y.M., An L.J. Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction in rotenone-induced PC12 cells. Toxicol. In Vitro 2008, 22:430-437.
37. Luo Y., Hurwitz J., Massague J. cell cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 1995, 375:159-161.
38. Michalke B., Halbach S., Nischwitz V. Speciation and toxicological relevance of manganese in humans. J. Environ. Monit. 2007, 9:650-656.
39. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65(1-2):55-63.
40. Nakanishi M., Adami G.R., Robetorye R.S., Noda A., Venable S.F., Dimitrov D., Pereira-Smith O.M., Smith J.R. Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc. Natl. Acad. Sci. U S A 1995, 92:4352-4356.
41. Nakanishi M., Robetorye R.S., Adami G.R., Pereira-Smith O.M., Smith J.R. Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J. 1995, 14:555-563.
42. Periyasamy S., Ammanamanchi S., Tillekeratne M.P., Brattain M.G. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Oncogene 2000, 19:4660-4667.
43. Posser T., Franco J.L., Bobrovskaya L., Leal R.B., Dickson P.W., Dunkley P.R. Manganese induces sustained Ser40 phosphorylation and activation of tyrosine hydroxylase in PC12 cells. J. Neurochem. 2009, 110(3):848-856.
44. Ranganathan S., Bowser R. Alterations in G(1) to S phase cell cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol. 2003, 162:823-835.
45. Reed S.I. The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol. 1992, 8:529-561.
46. Sengupta A., Mense S.M., Lan C., Zhou M., Mauro R.E., Kellerman L., Bentsman G., Volsky D.J., Louis E.D., Graziano J.H., Zhang L. Gene expression profiling of human primary astrocytes exposed to manganese chloride indicates selective effects on several functions of the cells. Neurotoxicology 2007, 28:478-489.
47. Sheaff R.J., Singer J.D., Swanger J., Smitherman M., Roberts J.M., Clurman B.E. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell 2000, 5:403-410.
48. Sherr C.J. G1 phase progression: cycling on cue. Cell 1994, 79:551-555.
49. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995, 9:1149-1163.
50. Shiohara M., Akashi M., Gombart A.F., Yang R., Koeffler H.P. Tumor necrosis factor alpha: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. J. Cell. Physiol. 1996, 166:568-576.
51. Smits V.A., Klompmaker R., Vallenius T., Rijksen G., Makela T.P., Medema R.H. P21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J. Biol. Chem. 2000, 275:30638-30643.
52. Westfall M.D., Mays D.J., Sniezek J.C., Pietenpol J.A. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell. Biol. 2003, 23:2264-2276.
53. Zhao P., Zhong W., Ying X., Yuan Z., Fu J., Zhou Z. Manganese chloride-induced G0/G1 and S phase arrest in A549 cells. Toxicology 2008, 250:39-46.
54. Zhao F., Cai T., Liu M., Zheng G., Luo W., Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol. Sci. 2009, 107(1):156-164.
55. Zhu X., Raina A.K., Perry G., Smith M.A. Alzheimer's disease: the two-hit hypothesis. Lancet Neurol. 2004, 3:219-226.
56. Zwingmann C., Leibfritz D., Hazell A.S. Nmr spectroscopic analysis of regional brain energy metabolism in manganese neurotoxicity. Glia 2007, 55:1610-1617.